Plexus Corp. is a publicly traded electronics manufacturing services provider that helps other companies bring complex products to market. Rather than selling finished goods under its own name, Plexus designs, engineers, and manufactures products on behalf of customers in industries where precision, quality, and regulatory compliance are critical. Investors follow PLXS because its performance offers a window into demand trends across healthcare technology, industrial automation, and defense supply chains. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Plexus was founded in 1979 and is headquartered in Neenah, Wisconsin. The company has grown into a global operation with roughly 20,000 employees and manufacturing facilities spread across the Americas, Asia-Pacific, and EMEA. Its shares trade on the Nasdaq under the ticker PLXS.
Plexus operates as an EMS provider, which means it offers design, supply chain, new product introduction (NPI), manufacturing, and aftermarket "sustaining" services across the full lifecycle of a product. This business model lets customers outsource the engineering and production of complex hardware while retaining ownership of their own brands and intellectual property.
The company organizes its business into three reportable geographic segments. The AMER segment covers the Americas, APAC covers Asia-Pacific, and EMEA covers Europe, the Middle East, and Africa. Its end markets include Healthcare/Life Sciences (such as medical devices and diagnostic equipment), Industrial (including industrial automation and semiconductor capital equipment), and Aerospace/Defense, which focuses on mission-critical systems with stringent regulatory oversight.
Plexus competes in a broad EMS market alongside other contract manufacturers that produce electronics for original equipment manufacturers (OEMs). What differentiates Plexus is its focus on relatively complex, regulated products rather than high-volume commodity electronics. By targeting demanding sectors, the company aims to build deeper, longer-lasting customer relationships that are harder for competitors to displace.
The company's financial profile reflects this positioning. In fiscal 2024, Plexus reported net sales of approximately $3.96 billion, with the Healthcare/Life Sciences and Industrial sectors each contributing a large share of revenue and Aerospace/Defense growing strongly year over year. In fiscal 2025, net sales rose to approximately $4.03 billion.
Investors monitor PLXS for several reasons. First, its diversified end-market exposure spans healthcare, industrial, and defense — sectors with distinct demand drivers that can offset weakness in any single area. Aerospace/Defense, for example, has been a growth area supported by resilient government and commercial demand.
Second, Plexus's emphasis on complex, regulated products can support stickier customer relationships and more stable program revenue over time. Third, the company's global manufacturing footprint gives it supply chain flexibility and access to customers across major regions. Investors also watch its ability to win new programs and convert them into sustained production revenue, since new program wins are a leading indicator of future sales. From what I see, this diversification helps provide some balance in a volatile sector.
Investing in Plexus carries meaningful risks. The company has a concentrated customer base, with its top customers historically accounting for a substantial portion of net sales. Losing a major account or a large program can materially affect revenue. The EMS industry is also competitive, and customer demand is sensitive to macroeconomic conditions, inventory cycles, and component pricing.
Plexus's operations are exposed to geopolitical and supply chain risks, particularly given its significant manufacturing presence in Asia. Shifts in trade policy, tariffs, or regional disruptions can raise costs or force production changes. Additionally, demand in sectors such as Healthcare/Life Sciences and Industrial has at times been volatile, and the company has periodically undertaken restructuring actions to manage costs. These factors make Plexus's financial results sensitive to forces beyond its direct control.
Plexus Corp. is a distinctive player in the electronics manufacturing services industry, pairing global scale with a focus on complex, regulated products in healthcare, industrial, and aerospace/defense markets. Its business model thrives on long-term OEM partnerships and full-lifecycle support, which has helped it build a meaningful market position. For investors, PLXS offers exposure to multiple technology-driven end markets, though that exposure comes with customer concentration, competitive, and supply chain risks worth understanding.
When researching companies like Plexus, I find Tickeron’s AI Screener helpful for quickly comparing technical indicators, fundamentals, and industry trends across thousands of stocks. It allows users to apply customizable filters and AI-generated signals to surface ideas that align with specific strategies, which can streamline the research process for investors tracking EMS providers and related sectors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
On November 11, 2026, the Stochastic Oscillator for PLXS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 53 instances where the indicator left the oversold zone. In 42 of the 53 cases the stock moved higher in the following days. This puts the odds of a move higher at over 79%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PLXS's RSI Indicator exited the oversold zone, 13 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on PLXS as a result. In 62 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for PLXS just turned positive on November 12, 2026. Looking at past instances where PLXS's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.
Following a +9.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where PLXS advanced for three days, in 238 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
PLXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
PLXS moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PLXS crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
The 50-day moving average for PLXS moved below the 200-day moving average on November 11, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLXS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
The Aroon Indicator for PLXS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. PLXS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.350) is normal, around the industry mean (3.856). P/E Ratio (27.770) is within average values for comparable stocks, (6.228). Projected Growth (PEG Ratio) (0.760) is also within normal values, averaging (0.930). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (1.443) is also within normal values, averaging (4.422).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of electronic manufacturing services
Industry ElectronicComponents